Skip to content

AUPH

Aurinia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$16.90
−0.35%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
21.67x
P/E 2026E
17.86x
P/E 2027E
14.32x
P/E 2028E
11.74x
P/S forward
6.58x

Trailing multiples

Trailing twelve months

P/E TTM
7.16x
PEG TTM
Price / book
3.66x
Price / sales
7.22x
Price / cash flow
12.94x

Enterprise value

Enterprise value
$1.9B
EV / sales
5.99x
EV / EBITDA
9.91x
EV / EBIT
12.38x
Market cap
$2.2B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026